Catalent, Inc. IPO Research Information

Catalent, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Catalent, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Catalent, Inc.	CTLT - NYSE	$19.00-$22.00	$20.50	$20.00	42.5 million	7/31/2014
Underwriter(s): Morgan Stanley, J.P. Morgan
Co-Manager(s): BofA Merrill Lynch, Goldman, Sachs & Co., Jefferies, Deutsche Bank Securities, Blackstone Capital Markets, Piper Jaffray, Raymond James, Wells Fargo Securities, William Blair, Evercore
Industry: Health Care
Filing(s): Filed 2014-01-24 Filed 2014-02-28 Underwriters Added 2014-05-05 Terms Added 2014-07-18

Catalent, Inc. Quote & Chart - Click for current quote - CTLT

About Catalent, Inc. (adapted from Catalent, Inc. prospectus):
They are the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "CTLT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.